NCT03472053 - A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions

Non Small Cell Lung Cancer Stage IIIB

Interventions

DRUG

BIO-11006 plus standard of care

BIO-11006 is administered 125mg BID plus standard of care.

DRUG

Standard of Care

Pemetrexed (500 mg/meter square) and Carboplatin (AUC6, Calvert's formula) are administered every three weeks for three months.

Trial Locations (11)

Vardhman Mahavir Medical College & Hospital, New Delhi

Aadhar Health Institute, Hisar

Nehru Hospital & Post Graduate Institute of Medical Education, Chandigarh

SMS Medical College & Hospital, Jaipur

Unique Hospital and Research Institute, Surat

Tata Memorial Hospital, Mumbai

Deenanath Mangeshkar Hospital & Research Center, Pune

Navsanjeevani Hospital, Nashik

HCG Manavata Cancer Center, Nashik

Chirayu Cancer Hospital, Bhopal

Sparsh Hospitals and Critical Care, Bhubaneswar